Monica M. Marcus

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism.

Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: May 06, 2022

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes.

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes.

Journal: Science advances

Published: September 03, 2020

Enhancement of the antipsychotic effect of risperidone by sodium nitroprusside in rats.

Enhancement of the antipsychotic effect of risperidone by sodium nitroprusside in rats.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: October 05, 2018

Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia.

Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: March 01, 2017

The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism.

The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: August 03, 2016

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: March 11, 2016

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.

Journal: The international journal of neuropsychopharmacology

Published: December 19, 2014

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: February 24, 2012

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: February 14, 2012

Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.

Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.

Journal: Synapse (New York, N.Y.)

Published: December 29, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026